Agios stockholders approve 2023 Stock Incentive Plan; elect three Class I directors

AGIOS PHARMACEUTICALS, INC.

Elected Rahul Ballal, Brian Goff, and Cynthia Smith as Class I directors for terms expiring at the 2026 annual meeting.
2023 Stock Incentive Plan approved with 27,268,226 votes for, 23,635,666 against, and 25,531 abstentions.
Non-binding advisory vote on named executive officer compensation passed (46,289,192 for, 4,630,627 against).
PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2023 (50,024,364 for, 1,876,012 against).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

AGIOS PHARMACEUTICALS, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-04-26 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-04-26

Exact text from the filing

The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the current fiscal year.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

AGIOS PHARMACEUTICALS, INC. shareholders approved Approval of the 2023 Plan at the 2023-04-26 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-04-26

Exact text from the filing

The Company’s stockholders approved the 2023 Plan.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

AGIOS PHARMACEUTICALS, INC. shareholders approved Election of Class I directors at the 2023-04-26 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-04-26

Exact text from the filing

The Company’s stockholders elected Rahul Ballal, Brian Goff and Cynthia Smith as Class I directors, each to serve for a three-year term expiring at the 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

AGIOS PHARMACEUTICALS, INC. shareholders approved Non-binding advisory vote on compensation paid to named executive officers at the 2023-04-26 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-04-26

Exact text from the filing

The Company’s stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.

View on SEC.gov

47 shareholder votes filed in the last 30 days. Browse all shareholder votes →

AGIOS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-166855

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.